
|Articles|September 15, 2004
Allergan enters patent battle over generic version of brimonidine tartrate solution
Irvine, CA-Allergan Inc. said it has filed a lawsuit against Alcon Laboratories Inc. claiming that the Fort Worth, TX company infringed upon Allergan's patents for brimonidine tartrate ophthalmic solution 0.15% to manufacture a generic alternative to its Alphagan P drops.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Beyond the surface: Tackling complex dry eye cases
2
SpyGlass Pharma releases positive data from 2 trials of Bimatoprost Drug Pad-IOL System
3
Redefining glaucoma care: Where innovation meets clinical insight
4
Seborrheic dermatitis linked to multiple epithelial barrier diseases
5


















































.png)


